Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
29A:FRA
Amphastar Pharmaceuticals, Inc
€ 17.98
+1.50%
(+0.27) Siku 1
28 Apr, 08:04:07 GMT +2  ·   EUR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 29A...
Fungua
€ 17.98
Juu
€ 17.98
Chini
€ 17.98
Mtaji wa soko
964.18M
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 25.96
Chini kwa wiki 52
€ 15.26
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products. One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally. In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case. In April 2023, Amphastar Pharmaceuticals bought Baqsimi from Eli Lilly in a deal worth over $1bn. Wikipedia
Kuhusu Amphastar Pharmaceuticals, Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 1.98
Lilianzishwa1996
Makao makuuRancho Cucamonga, California, Marekani
Sekta-
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
170.53M
174.41M
191.84M
183.10M
Gharama ya bidhaa zilizouzwa
85.28M
87.92M
93.19M
97.44M
Gharama ya mapato
85.28M
87.92M
93.19M
97.44M
Gharama za utafiti na maendeleo
20.10M
20.08M
22.35M
23.31M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
27.86M
24.23M
27.87M
26.75M
Gharama ya uendeshaji
47.96M
44.31M
50.23M
50.06M
Jumla ya gharama za uendeshaji
133.24M
132.23M
143.42M
147.50M
Mapato ya uendeshaji
37.29M
42.18M
48.42M
35.61M
Mapato mengine yasiyo ya uendeshaji
elfu 666.00
elfu -189.00
elfu 231.00
elfu 215.00
EBT ikijumuisha vipengee visivyo vya kawaida
30.86M
39.34M
21.51M
31.91M
EBT bila kujumuisha vipengee visivyo vya kawaida
30.86M
39.34M
44.61M
31.91M
Gharama ya kodi ya mapato
5.58M
8.30M
4.16M
7.48M
Kiwango cha kodi kinachotumika
18.07%
21.11%
19.35%
23.45%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
25.28M
31.03M
17.35M
24.43M
Kiwango cha faida halisi
14.83%
17.79%
9.04%
13.34%
Mapato kwa kila hisa
0.74
0.85
0.93
0.73
Mapato ya riba na uwekezaji
2.09M
1.92M
2.25M
2.42M
Gharama ya riba
-9.19M
-4.58M
-6.28M
-6.33M
Jumla ya gharama halisi za riba
-7.10M
-2.66M
-4.04M
-3.91M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
50.90M
56.80M
62.55M
49.95M
Faida au hasara kutokana na uuzaji wa vipengee
elfu 2.00
elfu 30.00
elfu 1.00
elfu 6.00
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi